Smartleaf Asset Management »

Mersana Therapeutics shares owned by Smartleaf Asset Management

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Smartleaf Asset Management from 13F filings

Historical chart of Smartleaf Asset Management investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Smartleaf Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Smartleaf Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.7k 5.3k 1.85
2024-06-30 $3.8k 1.9k 1.99

More positions owned by Smartleaf Asset Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard World Mega Cap Val Etf (MGV)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Wisdomtree Tr Us Quality Grow (QGRW)
Wisdomtree Tr Yield Enhancd Us (AGGY)
Alphabet Cap Stk Cl A (GOOGL)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Dimensional Etf Trust Us Core Equity 1 (DCOR)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Smartleaf Asset Management

Top funds holding Mersana Therapeutics

EcoR1 Capital
Nextech Invest
VR Adviser
Bain Capital Life Sciences Investors
BlackRock
BlackRock
Vanguard Group
Citadel Advisors
Rock Springs Capital Management
State Street Corporation
Cormorant Asset Management
Silverarc Capital Management
Geode Capital Management
Jpmorgan Chase & Co
Morgan Stanley

View all funds holding Mersana Therapeutics